Clinical Trial

Effects of E-Cigarette Flavors on Adult E-Cigarette Users With Opioid Use Disorder

Study acronym: FLAVOR
Completed
View on ClinicalTrials.gov →
Summary
This study examines the effects of e-cigarette (EC) flavors among adults with opioid use disorder (OUD) receiving buprenorphine treatment who currently use e-cigarettes. Participants will smell and rate 11 EC flavors based on appeal, sensory characteristics, and likelihood of future use. Researchers will examine how different flavor profiles influence the appeal and reinforcing effects of ECs in this population. The goal is to identify EC flavors that may enhance the acceptability of ECs as a potential harm-reduction strategy among adults with OUD receiving buprenorphine treatment.
Protocol Amendment History 1 change
critical Trial completed 2026-08-04
Trial Details
NCT Number NCT07594717
Lead Sponsor Prisma Health-Upstate
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Nicotine Use Disoder, Opioid Use Disorder
Enrollment 70 participants
Start Date 2025-11-12
Primary Completion 2026-04-28 (estimated)
Study Completion 2026-04-28 (estimated)
Updated on ClinicalTrials.gov 2026-08-03